Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE MA.

• 27th European Congress of Psychiatry, EPA 2019, Warsaw

• H.C. Wainwright & Co Global Life Sciences Conference, London

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the company will continue its institutional presence in several reputed international conferences in the upcoming weeks.

Click here to see the full Press Release